These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3546871)

  • 1. [Mizoribine-induced hyperuricemia].
    Ishikawa I; Maekawa S; Saito T; Horiguchi T; Shinoda A; Ishii H
    Nihon Jinzo Gakkai Shi; 1986 Oct; 28(10):1353-7. PubMed ID: 3546871
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperuricemia in Living Donor Kidney Transplantation Patients During Mizoribine Administration Caused Mainly by Changes in Kidney Function.
    Shi Y; Liu H; Chen XG; Shen ZY
    Transplant Proc; 2019 Jun; 51(5):1392-1396. PubMed ID: 31155176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hyperuricemia and acute kidney injury following kidney transplantation : a case report].
    Nakazawa S; Imamura R; Yamamoto Y; Hayashi T; Tanigawa G; Fujita K; Hosomi M; Yamaguchi S
    Hinyokika Kiyo; 2013 Feb; 59(2):103-6. PubMed ID: 23552752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute allograft renal failure with marked hyperuricemia developing during mizoribine administration: a case report with review of the literature.
    Guo HB
    Transplant Proc; 2010 Sep; 42(7):2804-7. PubMed ID: 20832593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of acute kidney injury with marked hyperuricemia during mizoribine administration.
    Nishino T; Shinzato T; Ohta Y; Yamashita H; Obata Y; Shinzato K; Kohno S
    Intern Med; 2012; 51(10):1239-43. PubMed ID: 22687797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of acute renal failure with marked hyperuricemia developing during mizoribine administration].
    Kushihata S; Hirabayashi A; Sekiguchi Y; Nagai K; Arata T
    Nihon Jinzo Gakkai Shi; 2002 Oct; 44(7):543-6. PubMed ID: 12476591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mizoribine as an alternative to azathioprine in triple-therapy immunosuppressant regimens in cadaveric renal transplantation.
    Lee HA; Slapak M; Venkatraman G; Mason J; Digard N; Wise M
    Transplant Proc; 1993 Aug; 25(4):2699-700. PubMed ID: 8356720
    [No Abstract]   [Full Text] [Related]  

  • 8. Is uric acid a predictive factor for graft dysfunction in renal transplant recipients?
    Akgul A; Bilgic A; Ibis A; Ozdemir FN; Arat Z; Haberal M
    Transplant Proc; 2007 May; 39(4):1023-6. PubMed ID: 17524881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between serum uric acid levels at 3 months after renal transplantation and the graft outcome in living donor renal transplantation.
    Choi JY; Kwon OJ
    Transplant Proc; 2013 May; 45(4):1548-52. PubMed ID: 23726617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with the use of mizoribine in human renal transplantation.
    Dohi K; Yahata H; Fukuda Y; Takenaka M; Tabe Y; Ono E; Fukuda M; Omotehara T; Eto T; Ezaki H
    Hiroshima J Med Sci; 1984 Dec; 33(4):809-12. PubMed ID: 6398817
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyperuricemia after renal transplantation.
    Kalantar E; Khalili N; Hossieni MS; Rostami Z; Einollahi B
    Transplant Proc; 2011 Mar; 43(2):584-5. PubMed ID: 21440768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of early-onset hyperuricemia in renal transplant recipients.
    Chung BH; Kang SH; Hwang HS; Choi BS; Park CW; Kim YS; Kim JI; Moon IS; Yang CW
    Nephron Clin Pract; 2011; 117(3):c276-83. PubMed ID: 20847570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperuricemia at 1 year after renal transplantation, its prevalence, associated factors, and graft survival.
    Numakura K; Satoh S; Tsuchiya N; Saito M; Maita S; Obara T; Tsuruta H; Inoue T; Narita S; Horikawa Y; Kagaya H; Miura M; Habuchi T
    Transplantation; 2012 Jul; 94(2):145-51. PubMed ID: 22728291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advantages of mizoribine over azathioprine in combination therapy with cyclosporine for renal transplantation.
    Mita K; Akiyama N; Nagao T; Sugimoto H; Inoue S; Osakabe T; Nakayama Y; Yokota K; Sato K; Uchida H
    Transplant Proc; 1990 Aug; 22(4):1679-81. PubMed ID: 2202125
    [No Abstract]   [Full Text] [Related]  

  • 15. Uric acid: a prognostic marker not only before but also after heart transplantation.
    António N; Prieto D; Antunes MJ
    Eur J Cardiothorac Surg; 2010 Aug; 38(2):187-91. PubMed ID: 20185326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The independent association between serum uric acid and graft outcomes after kidney transplantation.
    Haririan A; Nogueira JM; Zandi-Nejad K; Aiyer R; Hurley H; Cooper M; Klassen DK; Weir MR
    Transplantation; 2010 Mar; 89(5):573-9. PubMed ID: 19997058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uric acid has a J-shaped association with cardiovascular and all-cause mortality in kidney transplant recipients.
    Dahle DO; Jenssen T; Holdaas H; Leivestad T; Vårdal M; Mjøen G; Reisaeter AV; Toft I; Hartmann A
    Clin Transplant; 2014 Jan; 28(1):134-40. PubMed ID: 24372653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uric acid and allograft loss from interstitial fibrosis/tubular atrophy: post hoc analysis from the angiotensin II blockade in chronic allograft nephropathy trial.
    Hart A; Jackson S; Kasiske BL; Mauer MS; Najafian B; Matas AJ; Spong R; Ibrahim HN
    Transplantation; 2014 May; 97(10):1066-71. PubMed ID: 24503762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new triple-drug induction therapy with low dose cyclosporine, mizoribine and prednisolone in renal transplantation.
    Kokado Y; Ishibashi M; Jiang H; Takahara S; Sonoda T
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1575-8. PubMed ID: 2652512
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunosuppressive effect of bredinin in the management of patients with renal transplantation.
    Kusaba R; Otubo O; Sugimoto H; Takahashi I; Yamada Y; Yamauchi J; Akiyama N; Inou T
    Proc Eur Dial Transplant Assoc; 1981; 18():420-5. PubMed ID: 7036163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.